AGER and type 2 diabetes mellitus: Rodent models of T2DM have slender, weaker femurs, and extensive bone loss indicating qualitative changes (proposed to be mediated by advanced glycation end products (AGE)/receptor for advanced glycation end products (RAGE)) may play a role in BMD fracture risk discordance [9,10].